Despite its structural similarity using the IL-1 receptor family, ST2 will not bind to either IL-1 or IL-1. 35, 60 and 100 times post infection.
Structure-Based Design of mTORC1 Inhibitors in Cancer Therapy
mTORC1 inhibitor
mTORC1 inhibitor
Despite its structural similarity using the IL-1 receptor family, ST2 will not bind to either IL-1 or IL-1. 35, 60 and 100 times post infection.